During an April 23rd FDA hearing to gather input on ways to modernize the clinical research process, The Association of Clinical Research Organizations (ACRO) provided FDA a number of suggestions to improve the drug development process. ACRO’s main suggestion was to...
According to a report by the Institute of Medicine (IOM), the National Cancer Institute’s (NCI) Clinical Trials Cooperative Group program was inefficient, underfunded, and filled with red tape. The NCI program contains 3,100 institutions in the U.S., Canada, and...
PharmaVOICE has featured Pearl Pathways twice in the last year. In January 2012, Pearl President and CEO, Diana Caldwell, shared her thoughts on the expansion of Pearl’s services to meet the growing needs of their customers. In April 2012, Chief Operating...
Please join us at the IHIF Annual Meeting from May 7-8. Pearl will be in attendance with 3-4 teammates so be sure to look for us! The topic of the event is: “Statewide Strategic Plan for the Health Sector”. To learn more and to register, click...
The fourth annual meeting of the Indiana Clinical and Translational Sciences Institute (CTSI) will be held on Friday, August 31, 2012. The event is free and will take place at the University Place Conference Center and Hotel on the IUPUI campus. Discussions will be...
